New York Senate Bill S04163, known as the "Health Insurance Preauthorization Disclosure Act," mandates that health insurance companies provide participating healthcare providers with an updated list of treatments and services requiring preauthorization. This list must be developed in consultation with relevant medical guidelines and regional physicians, and updated annually or more frequently as appropriate. Any new services added to the list must be communicated to providers at least 90 days in advance. ([legiscan.com](https://legiscan.com/NY/text/S04163/id/3095274?utm_source=openai))
The bill aligns with ongoing efforts to streamline the prior authorization process in healthcare. In May 2026, Dr. Mehmet Oz announced a coalition of 29 major healthcare organizations aiming to simplify prior authorizations, highlighting a collective move towards reducing administrative burdens. ([axios.com](https://www.axios.com/2026/05/13/dr-oz-prior-authorization-health-insurance?utm_source=openai))
Despite similar initiatives, skepticism remains about the effectiveness of such reforms. A 2024 survey by the American Medical Association found that 93% of physicians reported treatment delays due to prior authorizations, with over a quarter citing serious adverse events. ([time.com](https://time.com/7297420/health-insurance-prior-authorization/?utm_source=openai))
About This Analysis
This summary was generated using AI from the bill's official text and metadata. Data sourced from LegiScan and the New York State Legislature. Conflict-of-interest analysis for this bill is coming soon.
NY S04163